Skip to content
PatentBrief
Get alertsTop ↑

Boosting Plant Gene Editing and Regeneration with Special Genes

This patent describes a method to make plant genetic engineering more efficient by adding specific genes that encourage plant cells to divide and grow, making it easier to create new plants with desired traits.

Granted 2025ActiveExpires 2041Owned by Tianjin Genovo Biotechnology CoInvented by Kang Zhang, Caixia GAO, Yidong Ran + 3 more

Original patent title: “Method for improving plant genetic transformation and gene editing efficiency

Plain-English explanation by SahiLast reviewed · June 27, 2026

This patent describes a method to make plant genetic engineering more efficient by adding specific genes that encourage plant cells to divide and grow, making it easier to create new plants with desired traits. Granted to Tianjin Genovo Biotechnology Co in 2025 with 15 claims and 1 forward citation, and it is expected to expire in 2041.

Coverage

What does this patent actually cover?

This method improves how well plant cells regenerate into whole plants and how efficiently genes can be edited or added. It works by introducing specific combinations of genes into a plant cell. For example, ClaimclaimA numbered sentence at the end of a patent that legally defines what the inventor owns. The most important section.Read more → 1 describes introducing an expression construct containing the WUS, BBM, and SERK genes (or GRF and GIF genes, or the nucleotide sequence of SEQ ID NO: 22) to boost the plant cell's ability to regenerate. Claim 2 applies this same gene introduction step to help transform a plant with an "exogenous nucleic acid sequence of interest," meaning a new piece of DNA. Claim 3 extends this to gene editing, where the introduced genes help a gene editing system (like CRISPR) work better to modify the plant's own DNA. After these genes are introduced, an intact plant is regenerated from the modified cell.

The gap

What does this patent NOT cover?

  • Does not cover plant genetic transformation or gene editing methods that do not involve introducing the specific WUS, BBM, SERK, GRF, GIF, or SEQ ID NO: 22 nucleic acid sequences.
  • Does not cover methods that improve plant regeneration or gene editing using entirely different sets of cell division-promoting genes.
  • Does not cover genetic modification techniques that do not require regenerating an intact plant from a single plant cell.
  • Does not cover gene editing or genetic transformation in animals, fungi, or other non-plant organisms.
  • Does not cover methods where the WUS, BBM, and SERK genes are not introduced together, unless the GRF and GIF genes or SEQ ID NO: 22 are used instead.

These exclusions are unique to PatentBrief — derived from the actual claim language, not patent-office boilerplate.

Key facts

Patent numberUS 12416013
StatusActive
FieldBiotech & Medicine
AssigneeTianjin Genovo Biotechnology Co
InventorsKang Zhang, Caixia GAO, Yidong Ran and 3 others
Filed2021
Granted2025
Expires2041
Claims15
Times cited1
LitigationNone on record
Value · $108K$346KModest

What made this novel

The clever bit is identifying and leveraging specific combinations of known plant developmental genes (WUS, BBM, SERK, GRF, GIF) to significantly overcome the inherent difficulty of regenerating whole plants from genetically modified cells. This targeted genetic intervention directly addresses a major bottleneck in plant biotechnology.

The Patent Drawing

Representative patent drawing for Method for improving plant genetic transformation and gene editing efficiency (US 12416013)
Representative figure · US 12416013All figures on Google Patents →
Method for improving plant gen…(Primary claim)biotechagriculturegene editing

Schematic visualization of the patent's claim structure. Hand-drawn diagrams in progress for each landmark patent.

Where you've seen this

Real-world examples

01

Development of disease-resistant corn varieties

02

Creation of drought-tolerant soybean plants

03

Engineering rice with enhanced nutritional content

04

Accelerated breeding of new crop varieties through gene editing

Why it matters

The bigger picture

Plant genetic engineering is a crucial technology for developing crops with improved traits like disease resistance, higher yields, or enhanced nutritional value. The ability to efficiently regenerate a whole plant from a single modified cell is often a bottleneck in this process. By making this step more efficient, this patent could accelerate the development and testing of new genetically modified or gene-edited crops, potentially leading to more resilient and productive agricultural systems.

Filed

March 19, 2021

Granted

September 16, 2025

Market context

Who's building on this

Companies in this space

Companies like Tianjin Genovo Biotechnology Co Ltd, the assigneeassigneeThe entity that owns the patent — usually the inventor's employer or a company.Read more →, are actively working in this space. Major agricultural biotechnology firms such as Corteva Agriscience, Bayer Crop Science, and Syngenta, along with numerous academic research institutions worldwide, are continuously seeking ways to improve plant genetic transformation and gene editing efficiency to develop new crop varieties.

Market impact

This patent addresses a critical technical challenge in plant biotechnology, which could lead to a significant acceleration in the research and development pipeline for new genetically engineered and gene-edited crops. By making the transformation and regeneration process more efficient, it could reduce the time and cost associated with bringing new crop traits to market, thereby increasing the pace of innovation in the agricultural sector and potentially enabling the development of crops previously too difficult to modify.

Claim 1 — Plain English

What this patent covers

This method improves how well plant cells regenerate into whole plants and how efficiently genes can be edited or added. It works by introducing specific combinations of genes into a plant cell. For example, Claim 1 describes introducing an expression construct containing the WUS, BBM, and SERK genes (or GRF and GIF genes, or the nucleotide sequence of SEQ ID NO: 22) to boost the plant cell's ability to regenerate. Claim 2 applies this same gene introduction step to help transform a plant with an "exogenous nucleic acid sequence of interest," meaning a new piece of DNA. Claim 3 extends this to gene editing, where the introduced genes help a gene editing system (like CRISPR) work better to modify the plant's own DNA. After these genes are introduced, an intact plant is regenerated from the modified cell.

The clever bit

The clever bit is identifying and leveraging specific combinations of known plant developmental genes (WUS, BBM, SERK, GRF, GIF) to significantly overcome the inherent difficulty of regenerating whole plants from genetically modified cells. This targeted genetic intervention directly addresses a major bottleneck in plant biotechnology.

What it does not cover

  • Does not cover plant genetic transformation or gene editing methods that do not involve introducing the specific WUS, BBM, SERK, GRF, GIF, or SEQ ID NO: 22 nucleic acid sequences.
  • Does not cover methods that improve plant regeneration or gene editing using entirely different sets of cell division-promoting genes.
  • Does not cover genetic modification techniques that do not require regenerating an intact plant from a single plant cell.
  • Does not cover gene editing or genetic transformation in animals, fungi, or other non-plant organisms.
  • Does not cover methods where the WUS, BBM, and SERK genes are not introduced together, unless the GRF and GIF genes or SEQ ID NO: 22 are used instead.

Patent timeline

Filing

Application submitted to the patent office

Publication

Application published, typically 18 months after filing

Grant

Patent officially issued

Expiration

Patent enters public domain

PatentBrief Score

Impact Score

Moderate

Citation count

6/40

Early citations

Claim breadth

10/20

Broad claimsclaimsThe numbered statements at the end of a patent that legally define what the inventor owns.Read more →

Recency

20/20

Granted within 5 years

Assignee scale

20/20

Major company or institution

PatentBrief Impact Score — based on citation count, claim breadth, recency, and assignee scale. Not a legal assessment.

Heuristic Value Estimate

What this patent might be worth

Modest

$108K$346K

Midpoint $216K · 14.7 yr remaining · industry ×3.0

Adjust inputs →

Heuristic only — blends forward/backward citation counts, claim scope, time remaining, litigation history, and CPC-derived industry baseline. Real valuations need a professional appraisal.

The original legal language

Original claims

15 claims as filed with the patent office.

Concepts involved

ClaimPrior artNon-obviousnessNoveltySpecificationAssigneePatent term

Citations

Patent lineage

Cites earlier patents

7

earlier patents this invention cites as foundations

View prior art →

Cited by later patents

1

later patents that build on this invention

View patents →

Cite this patent

Zhang, K., GAO, C., Ran, Y., Qiu, F., Xu, H., & WANG, Y. (2025). Boosting Plant Gene Editing and Regeneration with Special Genes (U.S. Patent No. 12,416,013). U.S. Patent and Trademark Office. https://patentbrief.org/patent/us/12416013/method-for-improving-plant-genetic-transformation-and-gene-editing-efficiency

Auto-generated from the patent record. Double-check author order and the issue date against the official USPTO document before submitting.

Embed

Add this patent to your site

Drop this plain-English patent card into any blog post or article — free, no signup. It always links back to the full breakdown here.

<div data-patentlens-widget data-patent-number="US12416013"></div>
<script src="https://patentbrief.org/embed.js" async></script>

Stay in the loop

Get a weekly digest of new patents.

One email per week. No spam. Unsubscribe anytime.

Keep exploring

Related patents you should know

US 4683195 · 1987

How to Make Billions of Copies of a DNA Segment

This patent describes the Polymerase Chain Reaction (PCR), a method to rapidly create many copies of a specific piece of DNA or RNA, enabling its detection and analysis.

Cetus Corp

US 8697359 · 2014

How to Edit Genes in Human Cells Using an Engineered CRISPR System

This patent describes an engineered CRISPR-Cas9 system for precisely cutting DNA in eukaryotic cells to change how genes work, opening the door for gene editing in complex organisms.

Massachusetts Institute of Technology

US 7657849 · 2010

How the iPhone's Slide-to-Unlock Gesture Works

Apple's 2010 patent describes unlocking a device by dragging a specific graphical image across the touchscreen along a predefined path, a gesture that became iconic with the original iPhone.

Apple Inc

US 4733665 · 1988

How Doctors Implant a Permanent Stent Using a Balloon

This patent describes the method for placing a permanent, expandable wire mesh tube inside a blood vessel or other body tube using a balloon-tipped catheter to widen it and keep it open.

Expandable Grafts Partnership

US 4965188 · 1990

How to Make Many Copies of a DNA Piece with Heat

This patent describes the Polymerase Chain Reaction (PCR) method, a technique to make millions of copies of a specific DNA segment using a heat-resistant enzyme and repeated temperature changes.

Cetus Corp

US 4235871 · 1980

How to Encapsulate Active Materials in Lipid Bubbles Efficiently

This patent describes a method for trapping biologically active substances inside tiny, multi-layered fat bubbles called liposomes, using a specific water-in-oil emulsion and gel-forming process to improve how much material gets captured.

Individual

Semantically similar

You might also find these interesting

SEARCH ALL

More to explore

More in Biotech & Medicine

Browse all Biotech & Medicine

New to patents?

What is a patent?How to read a patentAnatomy of a claimHow strong is this patent?What the citations meanWhat it doesn't coverBiotech PatentsPatent glossary

Common Questions

Frequently Asked Questions

What does Boosting Plant Gene Editing and Regeneration with Special Genes cover?

This patent describes a method to make plant genetic engineering more efficient by adding specific genes that encourage plant cells to divide and grow, making it easier to create new plants with desired traits.

Who owns patent US 12416013?

Tianjin Genovo Biotechnology Co owns this patent, granted in 2025.

When does this patent expire?

This patent is expected to expire on March 19, 2041, when the invention enters the public domain.

What is patent US 12416013 cited by?

This patent has been cited by 1 later patents that build on its ideas.

What problem does this patent solve?

Plant genetic engineering is a crucial technology for developing crops with improved traits like disease resistance, higher yields, or enhanced nutritional value. The ability to efficiently regenerate a whole plant from a single modified cell is often a bottleneck in this process. By making this step more efficient, this patent could accelerate the development and testing of new genetically modified or gene-edited crops, potentially leading to more resilient and productive agricultural systems.

What does this patent NOT cover?

Does not cover plant genetic transformation or gene editing methods that do not involve introducing the specific WUS, BBM, SERK, GRF, GIF, or SEQ ID NO: 22 nucleic acid sequences.

Patent monitoring

Get notified when Tianjin Genovo Biotechnology Co files a new patent

Get notified when this company files a new patent. Weekly digest · Confirm via email · Unsubscribe anytime.

Last reviewed: June 27, 2026 · PatentBrief is not a law firm and this is not legal advice.